BE815488A - Imidazolido (1,5-C) thiazolidine-3-spiro-4'-piperidins - and use in treating schizophrenia, manic and psychoneurotic states - Google Patents
Imidazolido (1,5-C) thiazolidine-3-spiro-4'-piperidins - and use in treating schizophrenia, manic and psychoneurotic statesInfo
- Publication number
- BE815488A BE815488A BE144705A BE144705A BE815488A BE 815488 A BE815488 A BE 815488A BE 144705 A BE144705 A BE 144705A BE 144705 A BE144705 A BE 144705A BE 815488 A BE815488 A BE 815488A
- Authority
- BE
- Belgium
- Prior art keywords
- manic
- cpds
- treating schizophrenia
- imidazolido
- piperidins
- Prior art date
Links
- 206010026749 Mania Diseases 0.000 title abstract 2
- 201000000980 schizophrenia Diseases 0.000 title abstract 2
- -1 4,5,6-trimethoxybenzyl Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- RHCSKNNOAZULRK-UHFFFAOYSA-N mescaline Chemical compound COC1=CC(CCN)=CC(OC)=C1OC RHCSKNNOAZULRK-UHFFFAOYSA-N 0.000 abstract 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 abstract 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 abstract 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 abstract 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 abstract 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 230000016571 aggressive behavior Effects 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 abstract 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 abstract 1
- 230000004899 motility Effects 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- BMXXSXQVMCXGJM-UHFFFAOYSA-N pipamperone dihydrochloride Chemical compound [Cl-].[Cl-].C1CC(C(=O)N)([NH+]2CCCCC2)CC[NH+]1CCCC(=O)C1=CC=C(F)C=C1 BMXXSXQVMCXGJM-UHFFFAOYSA-N 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 abstract 1
- 229960003147 reserpine Drugs 0.000 abstract 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000002269 spontaneous effect Effects 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5999173A JPS5315073B2 (https=) | 1973-05-28 | 1973-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE815488A true BE815488A (en) | 1974-09-16 |
Family
ID=13129131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE144705A BE815488A (en) | 1973-05-28 | 1974-05-24 | Imidazolido (1,5-C) thiazolidine-3-spiro-4'-piperidins - and use in treating schizophrenia, manic and psychoneurotic states |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS5315073B2 (https=) |
| BE (1) | BE815488A (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU752031B2 (en) * | 1998-05-08 | 2002-09-05 | Toyama Chemical Co. Ltd. | Novel spiro compounds or salts thereof, agent for preventing and/or treating autoimmune diseases and AP-1 inhibitors containing the same |
-
1973
- 1973-05-28 JP JP5999173A patent/JPS5315073B2/ja not_active Expired
-
1974
- 1974-05-24 BE BE144705A patent/BE815488A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS505392A (https=) | 1975-01-21 |
| JPS5315073B2 (https=) | 1978-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO920494L (no) | Terapeutiske, heterosykliske forbindelser | |
| ES2122472T3 (es) | Derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. | |
| KR940007022A (ko) | 피패리딘 유도체, 이것의 제법 및 치료에 있어서 이것의 이용 | |
| ATE76625T1 (de) | Stabilisierte wasserstoffperoxidloesung. | |
| GR3000534T3 (en) | Aqueous alcaline injectable solution of torasemid ready for use and process for preparation thereof | |
| BE815488A (en) | Imidazolido (1,5-C) thiazolidine-3-spiro-4'-piperidins - and use in treating schizophrenia, manic and psychoneurotic states | |
| ES2151037T3 (es) | Aldolizacion selectiva de la acetona en diacetona-alcohol con un catalizador basico solido. | |
| BR0308431A (pt) | Parecoxib sódico cristalino | |
| DE3273975D1 (de) | Antiviral alpha, alpha-dialkyl adamantylethylamines | |
| ES2039460T3 (es) | Un procedimiento para producir una solucion inyectable de glicosido de antraciclina. | |
| SE8203053L (sv) | Cysteinderivat i form av disulfid | |
| JPS5770820A (en) | Immunoregulating agent | |
| FR2222092A1 (https=) | ||
| ES373657A1 (es) | Un procedimiento para la preparacion de derivados simetri- cos de di-hidrotriazina n-sustituidos. | |
| GB1420758A (en) | Anti-ulcer compositions | |
| BE808504A (en) | 2-Acylamino-benzimidazole derivs - antihypertensives and anthelmintics, produced by acylation of 2-aminobenzimidazoles | |
| FR2035783A1 (en) | (A) Cpds. of formula I and their therapeutically active acid addition salts: where n=4 or 5 z=1, 2 or 3 (aryl=Ph, R=R1=H, n=4 when z=3), R=H or lowe | |
| FR2252088A1 (en) | Antibacterial 1,2,4-triazin-5-ones - of varying activity, some with tranquillizing activity | |
| FR2108992A1 (en) | Penicillin v - ampicillin mixtures - gram positive and negative antibacterials | |
| ES8308335A1 (es) | Un procedimiento para la preparacion de nuevos derivados de desoxiuridina. | |
| KR880011175A (ko) | 세팔로스포린 유도체 및 이의 제조방법 | |
| ES2073725T3 (es) | Derivados de 1,2,3,4-tetrahidronaftilamina dotados de actividad nootropica y composiciones farmaceuticas que los contienen. | |
| Silva Stevens et al. | Riboflavin-sensitized photoprocesses of tryptophan | |
| GB997011A (en) | Improvements in or relating to thraxanthene derivatives | |
| MX9703365A (es) | Derivados de carbohidrato. |